Direct Superior Approach Versus PosteroLateral Approach in Total Hip Arthroplasty (SPLAsH)

Recruiting N/A Interventional Study
Osteoarthritis, Hip
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 99
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
211 (estimated)
Sponsor
Isala · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This study will compare postoperative pain, health related quality of life (HRQoL), function, rehabilitation, urinary incontinence, muscle atrophy and component positioning in total hip arthroplasty (THA) using the posterolateral approach (PLA) or the direct superior approach (DSA). In addition, the CT images will be used to validate a new metal artefact reduction technique.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Subject * Has symptomatic incapacitating coxarthrosis in whom total hip arthroplasty (THA) is indicated, diagnosed by both physical examination and pelvic/hip X-ray * Has signed informed consent * Is ageing 18 years or older at time of study entry * Is competent and able to par…
Contacts

Harmen Ettema, MD/PhD

0031886245656

h.b.ettema@isala.nl

CONTACT

Roelina Munnik-Hagewoud, PhD

0031886245375

r.munnik@isala.nl

CONTACT